Key result
Acacia hydaspica extract significantly attenuates cisplatin-induced cardiotoxicity and oxidative stress in preclinical models.
Why the study?
Increased oxidative trauma is the main cause of cisplatin-induced cardiotoxicity, limiting its clinical use, and the protective potential of Acacia hydaspica against this cardiotoxicity was not evaluated.
Does Acacia hydaspica ethyl acetate extract prevent cisplatin-induced cardiotoxicity in rats?
Does Acacia hydaspica ethyl acetate extract prevent cisplatin-induced cardiotoxicity in rats?
Acacia hydaspica ethyl acetate extract shows potential in preventing cisplatin-induced cardiotoxicity in a rat model through antioxidant mechanisms.
Answers are grounded in this paper and cite their sources.
Acacia hydaspica extract attenuated cisplatin cardiotoxicity in rats; hypothesis-generating for human cardioprotection.
Background Increase oxidative trauma is the main cause behind Cisplatin (CP) induced cardiotoxicity which restricts its clinical application as anti-neoplastic prescription.Acacia hydaspicais a natural shrub with diverse bioactivities.Acacia hydaspicaethyl acetate extract (AHE) ameliorated drug-induced cardiotoxicity in animals with anti-oxidative mechanisms. Current study aimed to evaluate the protective potential ofA. hydaspicaagainst cisplatin-induced myocardial injury. Methods Rats were indiscriminately distributed into six groups (n = 6). Group 1: control; Groups 2: Injected with CP (7.5 mg/kg bw, i.p, single dose) on day 16; Group 3: Treated for 21 days with AHE (400 mg/kg b.w, oral); Group 4: Received CP injection on day 16 and treated with AHE for 5 days post injection; Group 5: Received AHE (400 mg/kg b.w/day, p.o.) for 21 days and CP (7.5 mg/kg b.w., i.p.) on day 16; Group 6: Treated with silymarin (100 mg/kg b.w., p.o.) after 1 day interval for 21 days and CP injection (7.5 mg/kg b.w., i.p.) on day 16. On 22nd day, the animals were sacrificed and their heart tissues were removed. Cisplatin induced cardiac toxicity and the influence of AHE were evaluated by examination of serum cardiac function markers, cardiac tissue antioxidant enzymes, oxidative stress markers and histology. Results CP inoculation considerably altered cardiac function biomarkers in serum and diminished the antioxidant enzymes levels, while increased oxidative stress biomarkers in cardiac tissues AHE treatment attenuated CP-induced deteriorations in creatine kinase (CK), Creatine kinase isoenzymes MB (CK-MB), cardiac Troponin I (cTNI) and lactate dehydrogenase (LDH) levels and ameliorated cardiac oxidative stress markers as evidenced by decreasing lipid peroxidation, H2O2and NO content along with augmentation in phase I and phase II antioxidant enzymes. Additionally, CP inoculation also induced morphological alterations which were ameliorated by AHE. In pretreatment group more significant protection was observed compared to post-treatment group indicating preventive potential of AHE. The protective potency of AHE was comparable to silymarin. Conclusion Results demonstrate that AHE attenuated CP induce cardiotoxicity. The polyphenolic metabolites and antioxidant properties of AHE might be responsible for its protective influence.
No takes yet. Share an insight, caveat, or question.
Afsar et al. (2019) studied Cisplatin-induced cardiotoxicity (n=36). Acacia hydaspica ethyl acetate extract (AHE) vs. Cisplatin alone (7.5 mg/kg b.w, i.p.) was evaluated on Cardiac function biomarkers (CK, CK-MB, LDH, cTnI) and oxidative stress markers (p=<0.0001). Acacia hydaspica ethyl acetate extract attenuated cisplatin-induced deteriorations in cardiac function biomarkers and ameliorated cardiac oxidative stress markers.
Synapse has enriched 10 related papers. Consider them for comparative context: